Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
34,214,175
-
Share change
-
-830,198
-
Total reported value
-
$69,793,002
-
Put/Call ratio
-
209%
-
Price per share
-
$2.04
-
Number of holders
-
46
-
Value change
-
-$2,634,282
-
Number of buys
-
11
-
Number of sells
-
38
Institutional Holders of STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) as of Q3 2021
As of 30 Sep 2021,
STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,214,175 shares.
The largest 10 holders included
CAXTON CORP, Stonepine Capital Management, LLC, NEA Management Company, LLC, Rubric Capital Management LP, VANGUARD GROUP INC, Man Group plc, MORGAN STANLEY, Tudor Investment Corp Et Al, RENAISSANCE TECHNOLOGIES LLC, and ORBIMED ADVISORS LLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.